About SpectraCure
SpectraCure is a company based in Lund (Sweden) founded in 2003. SpectraCure offers products and services including IDOSE Platform and Laser Unit. SpectraCure operates in a competitive market with competitors including PhotoPharmics, CranioVation, Lumeda, Adgero Biopharma and Photolitec, among others.
- Headquarter Lund, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spectracure Ab (Publ)
-
Annual Revenue
Not available
-
Net Profit
-$2.09 M (USD)-12.54as on Dec 31, 2024
-
EBITDA
-$1.98 M (USD)-2.26as on Dec 31, 2024
-
Latest Funding Round
$336.21 K (USD), Grant
Sep 01, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpectraCure
SpectraCure offers a comprehensive portfolio of products and services, including IDOSE Platform and Laser Unit.
Software for planning precise doses in photodynamic therapy treatments
Device that performs photodynamic therapy for prostate cancer
Funding Insights of SpectraCure
Investors in SpectraCure
SpectraCure has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for SpectraCure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpectraCure
Investment portfolio details for SpectraCure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SpectraCure
Detailed financials for SpectraCure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spectracure Comparisons
Peer comparison for SpectraCure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpectraCure
SpectraCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, CranioVation, Lumeda, Adgero Biopharma and Photolitec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Minimally invasive devices for brain tumor treatment are provided.
|
|
| Locked | Locked | Locked |
Photodynamic therapy device for lung cancer treatment is developed.
|
|
| Locked | Locked | Locked |
Photodynamic therapy for cutaneous metastatic breast cancer is developed.
|
|
| Locked | Locked | Locked |
Supplies photosensitizing compounds for tumor imaging and photodynamic cancer therapy.
|
Detailed competitors of SpectraCure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spectracure
Complete news archive for SpectraCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpectraCure
SpectraCure was founded in 2003 and raised its 1st funding round 17 years after it was founded.
SpectraCure is headquartered in Lund, Sweden.
SpectraCure is developing an interstitial photodynamic therapy for solid tumors (prostate and pancreas, as well as ENT). The treatment involves the administration of a photosensitizing drug and a non-thermal laser light under the management of a new dosimetry approach. They have proprietary software, iDOSE, for safe interstitial PDT treatment. iDOSE allows for 3D image-based treatment planning using advanced dose-planning tools to control light exposure.
SpectraCure's top competitors include PhotoPharmics, ImPact Biotech and Adgero Biopharma.
SpectraCure offers IDOSE Platform and Laser Unit.
SpectraCure has 1 investor. Key investors include European Union.